The aim has always been to bring all the threads together, patiently and thoroughly so that doctors and FDA could have absolute confidence in the product. I for financial reasons ( and I like a good time now) have had to let some of my position go. Am I upset you bet yah. But the prize is so...sooo enormous. If the device is good enough to get 3% of the market, what most analysts are using, then C-Pulse 2 is well good enough to get 20% plus of the market. Lonestar obviously rushed their product, bye bye Lonestar.
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held